Acutus Medical publishes in the present day 12-month information from the Uncover-AF trial of its AcQMap imaging and cardiac mapping system, exploring its use in atrial fibrillation ablation procedures persistent.
The take a look at outcomes had been introduced on the 24th Annual AF Symposium in Boston, the corporate based mostly in Carlsbad, California introduced.
Acutus Medical's AcQMap System is designed to detect and show greater decision, voltage-based cost supply maps, and is able to producing real-time 3D photos of the guts chamber utilizing ultrasound .
"Now we have been mapping arrhythmias with the identical know-how for many years with out asking if there’s a higher technique to find ablation targets and supply extra correct, patient-friendly therapy. The outcomes of the Uncover-AF trial display that with higher imaging, we will carry out patient-centered ablations with nice success, whereas dramatically enhancing the standard of life for sufferers. This superior cardiac imaging system permits you to paint a whole image in excessive definition in actual time. This is a crucial step in enhancing normal look after atrial fibrillation removing procedures, "mentioned Dr. Atul Verma, principal investigator.
Researchers taking part within the trial of 127 sufferers have explored using the AcQMap system together with numerous ablation applied sciences available on the market at 13 websites in Europe and Canada, mentioned Acutus.
The outcomes of the research indicated a 72.5% absence of AF after a single process, whereas post-ablation monitoring indicated that 89.6% of sufferers handled with a single process had no AF episode.
The info additionally indicated that 98% of sufferers had sinus rhythm on the finish of the process, with no AF being reported in 93% of sufferers with one or two procedures. In whole, 82.4% of sufferers reported having no episode of AF throughout the next 12 months, mentioned Acutus.
"Acutus Medical's fixed aim is to develop a know-how that accelerates the success and improves the outcomes of electrophysiology procedures. A historic lack of innovation in cardiac mapping has led to the unlucky and customary perception that repeated ablations are merely unavoidable; The outcomes of UNCOVER-AF recommend that we will do higher with AcQMap imaging and adaptive processing. These first outcomes solely touched the floor of the potential. An unprecedented readability with AcQMap might assist physicians enhance atrial fibrillation ablation outcomes by offering customized therapy choices and decreasing the necessity for repeat procedures. This enchancment saves time, reduces the monetary burden and, most significantly, improves the lives of sufferers, "mentioned Vince Burgess, Govt Director. m mentioned in a press launch.
Final Might, Acutus Medical declared Launches AcQMap Excessive Decision Imaging and Mapping System and the 3D mapping catheter that bears the identical title, touting that the system had been utilized in its first business procedures.
The put up workplace Acutus Medical boasts information from a 12-month AF-guided ablation trial guided by AcQMap appeared first on MassDevice.